Archive


Category: Cancer Diagnostics

  • Black Female Co-founders CancerIQ Raises $14M to Improve Cancer Early Detection and Prevention

    CancerIQ Co-Founders Feyi Olopade Ayodele & Olufunmilayo (Funmi) Olopade, MD What You Should Know: – CancerIQ, a Chicago-based platform powering early cancer detection and prevention across broad patient populations, announced today it closed a $14M Series B financing round. – The Series B round was co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures […]

  • Notable Labs Launches by Acquiring Rights to Volasertib – Will Use Data, AI to Fast-Track Cancer Treatment

    Thomas Bock, M.D., Chief Executive Officer of Notable What You Should Know: – Coming out of stealth, Notable Labs, a pioneer and developer of predictive precision medicines, is acquiring worldwide development and commercial rights to volasertib, a PLK-1 inhibitor in acute myeloid leukemia (AML) from Oncoheroes. – Notable will leverage its high-fidelity Predictive Precision Medicines Platform to identify […]

  • Health Innovators: Owlstone Medical’s Billy Boyle on breath biopsy technology

    In the latest episode of our Health Innovators series, Paul Tunnah speaks to Billy Boyle, co-founder and CEO of Owlstone Medical, one of the UK’s most promising diagnostic startups. The Cambridge, UK-based company is on a mission to save 100,000 lives and $1.5bn in healthcare costs with its breath biopsy platform for early detection of […]

  • UK Cancer Diagnostics Startup Biofidelity Raises $12M

    What You Should Know: – UK-based Biofidelity raises $12 million in Series A funding to accelerate the launch of disruptive cancer diagnostic technology. – The funding will be used to bring technology to market, enabling a dramatic simplification of precision genetic testing to ensure many more cancer patients receive optimal diagnosis and therapy. Biofidelity Ltd, a […]